Halozyme appoints Jim Daly to its board of directors
AI Summary
Halozyme Therapeutics appointed James "Jim" Daly to its board of directors.
Daly brings more than 30 years of biopharmaceutical commercial leadership experience.
Daly previously held senior roles at Incyte, Amgen and GlaxoSmithKline.
Halozyme Therapeutics has appointed James "Jim" Daly to its board of directors, adding more than 30 years of biopharmaceutical commercial leadership experience. Daly has held senior roles at Incyte, Amgen and GlaxoSmithKline.
The information on this website is generated using AI and we cannot guarantee its accuracy.
Please use it as reference information only.
Halozyme appoints Jim Daly to its board of directors - CoinPost Terminal